Factor This Power Engineering
Live Events
DTECH® Events
POWERGENâ¢
Calendar
Webinars
Podcasts
Contribute Content
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Smart Grids
Transmission
Hydropower
Dams & Civil Structures
Small Hydropower
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Project Development
Tariffs
Electric Vehicles
EV Charging
Vehicle to Grid
Subscribe
Solar
Community
Residential
Utility Scale
Wind Power
Offshore
Turbines & Equipment
Power Grid
Distribution
Grid Modernization
Microgrids
Outage Management
Transmission
Smart Grids
Hydropower
Dams & Civil Structures
Small Hydro
Technology & Equipment
Tidal & Wave Energy
Energy Storage
Battery
Long Duration
Pumped Storage
Business
Finance
Policy & Regulation
Electric Vehicles
EV Charging
Vehicle to Grid
Factor This: Power Engineering
Live Events
DISTRIBUTECH®
Podcasts
Webinars
Calendar
Contribute Content
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Imunon, Inc. - Common Stock
(NQ:
IMNN
)
3.995
-0.125 (-3.03%)
Streaming Delayed Price
Updated: 11:32 AM EST, Dec 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Imunon, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Imunon Highlights Early Data From Lead Program In Ovarian Cancer
↗
September 28, 2023
Imunon Inc (NASDAQ: IMNN) announces interim progression-free survival (PFS) and overall survival (OS) data with IMNN-001 in its Phase 1/2 OVATION 2 Study of intraperitoneal IMNN-001 in combination with...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
September 28, 2023
Via
Benzinga
Earnings Outlook For Imunon
↗
August 09, 2023
Via
Benzinga
Imunon: Q1 Earnings Insights
↗
May 11, 2023
Via
Benzinga
Imunon, Inc. - Common Stock Earnings Perspective: Return On Capital Employed
↗
March 31, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
March 30, 2023
Via
Benzinga
Imunon, Inc. - Common Stock Earnings Preview
↗
March 29, 2023
Via
Benzinga
Imunon, Inc. - Common Stock's Return On Capital Employed Overview
↗
December 23, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
↗
April 03, 2023
On Monday, 76 companies set new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
March 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
January 31, 2023
Via
Benzinga
IMUNON Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)
December 14, 2022
From
Imunon, Inc.
Via
GlobeNewswire
IMUNON Presentation at World Vaccine & Immunotherapy Congress Highlights PLACCINE Preclinical Proof of Concept and Key Competitive Advantages
December 01, 2022
From
Imunon, Inc.
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Wednesday
↗
November 30, 2022
During Wednesday's session, 107 stocks hit new 52-week lows.
Via
Benzinga
IMUNON to Participate in the A.G.P./Alliance Global Partners Virtual Biotech Conference on November 30, 2022 – December 1, 2022
November 22, 2022
From
Imunon, Inc.
Via
GlobeNewswire
IMUNON Announces Strategic Investment in Transomic Technologies
November 17, 2022
From
Imunon, Inc.
Via
GlobeNewswire
IMUNON Reports Third Quarter 2022 Financial Results and Provides Business Update
November 14, 2022
From
Imunon, Inc.
Via
GlobeNewswire
IMUNON Enters into Technology Evaluation Agreement with Acuitas Therapeutics to Evaluate IMUNON’s PLACCINE Plasmid DNA with Acuitas’ Lipid Nanoparticle Delivery System
November 10, 2022
From
Imunon, Inc.
Via
GlobeNewswire
Imunon to Hold Third Quarter 2022 Financial Results and Business Update Conference Call on Monday, November 14, 2022
November 07, 2022
From
Imunon, Inc.
Via
GlobeNewswire
Imunon Appoints James E. Dentzer to its Board of Directors
October 03, 2022
From
Imunon, Inc.
Via
GlobeNewswire
Imunon Reports Partial Results from Ongoing Non-human Primate Study
October 03, 2022
From
Imunon, Inc.
Via
GlobeNewswire
Imunon Reports Inducement Grants under NASDQ Listing Rule 5646(c)(4)
September 29, 2022
From
Imunon, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
